(NASDAQ: IFRX) Inflarx Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.52%.
Inflarx Nv's earnings in 2026 is -$46,631,580.On average, 9 Wall Street analysts forecast IFRX's earnings for 2026 to be -$46,691,322, with the lowest IFRX earnings forecast at -$81,662,391, and the highest IFRX earnings forecast at -$32,010,519. On average, 9 Wall Street analysts forecast IFRX's earnings for 2027 to be -$56,203,019, with the lowest IFRX earnings forecast at -$110,211,031, and the highest IFRX earnings forecast at -$32,721,864.
In 2028, IFRX is forecast to generate -$36,624,098 in earnings, with the lowest earnings forecast at -$42,084,517 and the highest earnings forecast at -$27,911,818.